Umaxlife

Umaxlife is redefining mental healthcare through digital therapeutics and AI-powered psychophysiological analytics, making mental health measurable, personalized, and an essential part of primary care. Our cloud-based platform empowers therapists and healthcare providers with evidence-based insights drawn from physiological and conversational data recorded during therapy sessions. Through advanced AI models, these insights are turned into clear, actionable progress reports—helping clinicians monitor outcomes, predict relapse risks, and personalize care with precision and empathy. Backed by two TÜBİTAK R&D grants, the Sanofi Care4Rare HealthTech Innovation Award, and AWS Activate credits, Umaxlife is developing a HIPAA-compliant, EU AI Act-ready digital medical platform designed for scalability and clinical reliability. Our mission is to make mental healthcare a measurable, accessible, and data-driven part of universal health coverage, aligning with WHO’s 2030 Mental Health Action Plan and supporting the global shift toward evidence-based, community integrated care.#MentalHealthInnovation #DigitalTherapeutics #AIinHealthcare #PrimaryCareIntegration #GlobalMentalHealth #WHO2030 #HealthTech #EUAIAct #AWSActivate #SanofiCare4Rare #startup #Care4Rare #Future4Care